Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ENHA
ENHA logo

ENHA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy A Paradise Acquisition Corp (ENHA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
4.430
1 Day change
11.03%
52 Week Range
--
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Based on the investor's beginner level, long-term investment strategy, and available capital, ENHA appears to be a good buy. The company has strong growth potential in the wellness and telehealth sectors, supported by positive analyst ratings and recent successful fundraising efforts. Despite the lack of technical trend data and trading signals, the long-term fundamentals and market positioning make this a compelling investment opportunity.

Technical Analysis

No trend data available for analysis. The stock showed a significant regular market change of 11.03%, indicating recent positive momentum.

Positive Catalysts

  • Raised $50 million through PIPE financing to enhance liquidity and accelerate growth.

  • Inaugural Enhanced Games attracted over one billion viewers and secured $32 million in sponsorships, demonstrating strong market appeal.

  • Analysts initiated coverage with Buy ratings and price targets significantly above the current price, citing hyper-growth potential in the wellness and longevity sectors.

Neutral/Negative Catalysts

  • Stock is down 70% since the SPAC deal, which may indicate prior investor skepticism or challenges in execution.

  • No significant hedge fund or insider trading trends to signal strong institutional confidence.

Financial Performance

No financial data available for the latest quarter. However, the company aims for operational profitability by 2027, supported by recent fundraising and sponsorship success.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have initiated coverage with Buy ratings and price targets ranging from $6 to $15, citing strong growth potential in the wellness and telehealth sectors. Enhanced's valuation is considered compelling for a hyper-growth company.

Wall Street analysts forecast ENHA stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast ENHA stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 3.990
sliders
Low
0
Averages
0
High
0
0
Current: 3.990
sliders
Low
0
Averages
0
High
0
Canaccord
Susan Anderson
Buy
initiated
$6
AI Analysis
2026-06-02
Reason
Canaccord
Susan Anderson
Price Target
$6
AI Analysis
2026-06-02
initiated
Buy
Reason
Canaccord analyst Susan Anderson initiated coverage of Enhanced Group with a Buy rating and $6 price target. Enhanced has a telehealth platform, nutrition and supplement offering, and a media and events platform, the analyst tells investors in a research note. The firm believes the company can benefit from the growing demand for solutions centered on healthy aging and modern wellness. With the stock down 70% since the de-special purpose acquisition company deal, Enhanced's valuation for a "potential hyper-growth company looks compelling," contends Canaccord.
Canaccord
Buy
initiated
$6
2026-06-02
Reason
Canaccord
Price Target
$6
2026-06-02
initiated
Buy
Reason
Canaccord initiated coverage of Enhanced Group with a Buy rating and $6 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ENHA
Unlock Now

People Also Watch